JP2000512316A - セルトラリンのゼラチンカプセル封入溶液剤形 - Google Patents
セルトラリンのゼラチンカプセル封入溶液剤形Info
- Publication number
- JP2000512316A JP2000512316A JP11506776A JP50677699A JP2000512316A JP 2000512316 A JP2000512316 A JP 2000512316A JP 11506776 A JP11506776 A JP 11506776A JP 50677699 A JP50677699 A JP 50677699A JP 2000512316 A JP2000512316 A JP 2000512316A
- Authority
- JP
- Japan
- Prior art keywords
- sertraline
- dosage form
- form according
- vehicle
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.セルトラリンまたはその医薬的に許容できる塩類および水−非混和性ビヒ クルを含むゼラチンカプセル封入組成物を含む剤形。 2.Tmaxを少なくとも0.5時間短縮する、請求項1記載の剤形。 3.Tmaxを少なくとも1時間短縮する、請求項2記載の剤形。 4.10〜300mgAのセルトラリンを含有する、請求項1記載の剤形。 5.10〜250mgAのセルトラリンを含有する、請求項4記載の剤形。 6.10〜100mgAのセルトラリンを含有する、請求項5記載の剤形。 7.ビヒクルがモノ−、ジ−もしくはトリグリセリドまたはその混合物を含む 、請求項1記載の剤形。 8.モノ−、ジ−もしくはトリグリセリドのアシル鎖(1またはそれ以上)が 平均4〜18炭素の長さである、請求項7記載の剤形。 9.モノ−、ジ−もしくはトリグリセリドのアシル鎖(1またはそれ以上)が 平均6〜14炭素の長さである、請求項8記載の剤形。 10.ビヒクルが37℃で液体である、請求項1記載の剤形。 11.ビヒクルが植物油を含む、請求項1記載の剤形。 12.植物油がトウモロコシ油、ラッカセイ油、ゴマ油、オリーブ油、ヒマシ 油、ヤシ油、綿実油、大豆油またはサフラワー油から選択される、請求項11記 載の剤形。 13.ビヒクルが界面活性剤または乳化剤を含む、請求項1記載の剤形。 14.界面活性剤または乳化剤がポリソルベート−80、ノニルフェノキシポ リオキシエチレン、スルホコハク酸ジオクチルナトリウム、PEG−6−グリセ リルモノオレエートまたはPEG−6−グリセリルリノレエートから選択される 、請求項13記載の剤形。 15.ビヒクルが脂肪酸を含む、請求項1記載の剤形。 16.脂肪酸がカプリル酸、カプリン酸、ラウリン酸、オレイン酸またはリノ ール酸から選択される、請求項15記載の剤形。 17.剤形が短鎖アルコールと酸の液体エステルを含む、請求項1記載の剤形 。 18.エステルがカプリル酸および/またはカプリン酸のプロピレングリコー ルエステルから選択される、請求項17記載の剤形。 19.ビヒクルがさらにアルコールを含む、請求項1記載の剤形。 20.アルコールがポリエチレングリコール、グリセリン、エタノールまたは プロピレングリコールである、請求項19記載の剤形。 21.水混和性ビヒクルを用いて製造した比較剤形と比較して、クロリドイオ ンを含有する使用環境中でのセルトラリンの沈殿を少なくする、請求項1記載の 剤形。 22.セルトラリンで処置できる疾病の処置方法であって、その処置を必要と する者に請求項1記載の剤形を投与することを含む方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5140197P | 1997-07-01 | 1997-07-01 | |
US60/051,401 | 1997-07-01 | ||
PCT/IB1998/000936 WO1999001113A1 (en) | 1997-07-01 | 1998-06-16 | Gelatine encapsulated solution dosage forms of sertraline |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000512316A true JP2000512316A (ja) | 2000-09-19 |
JP3585245B2 JP3585245B2 (ja) | 2004-11-04 |
Family
ID=21971076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50677699A Expired - Fee Related JP3585245B2 (ja) | 1997-07-01 | 1998-06-16 | セルトラリンのゼラチンカプセル封入溶液剤形 |
Country Status (40)
Country | Link |
---|---|
EP (1) | EP0980241B1 (ja) |
JP (1) | JP3585245B2 (ja) |
KR (1) | KR100371730B1 (ja) |
CN (1) | CN1261792A (ja) |
AP (1) | AP945A (ja) |
AR (1) | AR015916A1 (ja) |
AT (1) | ATE256457T1 (ja) |
AU (1) | AU724635B2 (ja) |
BG (1) | BG103917A (ja) |
BR (1) | BR9809712A (ja) |
CA (1) | CA2290973C (ja) |
CO (1) | CO4940405A1 (ja) |
DE (1) | DE69820608T2 (ja) |
DK (1) | DK0980241T3 (ja) |
DZ (1) | DZ2544A1 (ja) |
EA (1) | EA001905B1 (ja) |
ES (1) | ES2210760T3 (ja) |
GT (1) | GT199800090A (ja) |
HR (1) | HRP980378B1 (ja) |
HU (1) | HUP0002250A3 (ja) |
ID (1) | ID24673A (ja) |
IL (1) | IL133075A0 (ja) |
IS (1) | IS5266A (ja) |
MA (1) | MA24586A1 (ja) |
MY (1) | MY119728A (ja) |
NO (1) | NO996492L (ja) |
NZ (1) | NZ501252A (ja) |
OA (1) | OA11246A (ja) |
PA (1) | PA8454001A1 (ja) |
PE (1) | PE97299A1 (ja) |
PL (1) | PL337807A1 (ja) |
PT (1) | PT980241E (ja) |
SK (1) | SK282914B6 (ja) |
TN (1) | TNSN98123A1 (ja) |
TR (1) | TR199903282T2 (ja) |
TW (1) | TW382597B (ja) |
UA (1) | UA68350C2 (ja) |
UY (1) | UY25070A1 (ja) |
WO (1) | WO1999001113A1 (ja) |
ZA (1) | ZA985709B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2346335C (en) * | 1998-10-13 | 2006-04-18 | Pfizer Products Inc. | Sertraline oral concentrate |
US6727283B2 (en) | 1998-10-13 | 2004-04-27 | Pfizer Inc. | Sertraline oral concentrate |
AU762934B2 (en) | 1999-09-03 | 2003-07-10 | Allergan Sales, Llc | Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
WO2002017918A2 (en) | 2000-08-30 | 2002-03-07 | Pfizer Products Inc. | Sustained release formulations for growth hormone secretagogues |
EP1375659A1 (en) * | 2002-06-18 | 2004-01-02 | Laboratorio di Diagnostica Moleculare | Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions |
AR041745A1 (es) * | 2002-10-31 | 2005-05-26 | Alza Corp | Formulacion y forma de dosificacion que provee mayor biodisponibilidad de los farmacos hidrofobos |
WO2016020936A2 (en) * | 2014-07-21 | 2016-02-11 | Patel Jayendrakumar Dasharathlal | A novel oral gastroretentive pharmaceutical dosage form |
CN108014087A (zh) * | 2017-12-27 | 2018-05-11 | 江苏联环药业股份有限公司 | 一种盐酸舍曲林胶囊的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0782445B1 (en) * | 1994-09-19 | 2002-03-13 | Dupont Pharmaceuticals Company | Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
ATE235237T1 (de) * | 1995-07-17 | 2003-04-15 | Pfizer | Sertralin zur behandlung von post-myocard-infarkt-patienten |
-
1998
- 1998-06-16 BR BR9809712-1A patent/BR9809712A/pt not_active Application Discontinuation
- 1998-06-16 ES ES98923021T patent/ES2210760T3/es not_active Expired - Lifetime
- 1998-06-16 HU HU0002250A patent/HUP0002250A3/hu unknown
- 1998-06-16 AT AT98923021T patent/ATE256457T1/de not_active IP Right Cessation
- 1998-06-16 PT PT98923021T patent/PT980241E/pt unknown
- 1998-06-16 IL IL13307598A patent/IL133075A0/xx unknown
- 1998-06-16 PL PL98337807A patent/PL337807A1/xx unknown
- 1998-06-16 EA EA199900963A patent/EA001905B1/ru not_active IP Right Cessation
- 1998-06-16 SK SK1805-99A patent/SK282914B6/sk unknown
- 1998-06-16 TR TR1999/03282T patent/TR199903282T2/xx unknown
- 1998-06-16 JP JP50677699A patent/JP3585245B2/ja not_active Expired - Fee Related
- 1998-06-16 KR KR10-1999-7011596A patent/KR100371730B1/ko not_active IP Right Cessation
- 1998-06-16 EP EP98923021A patent/EP0980241B1/en not_active Expired - Lifetime
- 1998-06-16 AU AU75450/98A patent/AU724635B2/en not_active Ceased
- 1998-06-16 UA UA99116393A patent/UA68350C2/uk unknown
- 1998-06-16 ID IDW991697A patent/ID24673A/id unknown
- 1998-06-16 CA CA002290973A patent/CA2290973C/en not_active Expired - Fee Related
- 1998-06-16 DE DE69820608T patent/DE69820608T2/de not_active Expired - Fee Related
- 1998-06-16 WO PCT/IB1998/000936 patent/WO1999001113A1/en not_active Application Discontinuation
- 1998-06-16 DK DK98923021T patent/DK0980241T3/da active
- 1998-06-16 CN CN98806765A patent/CN1261792A/zh active Pending
- 1998-06-16 NZ NZ501252A patent/NZ501252A/en unknown
- 1998-06-19 PA PA19988454001A patent/PA8454001A1/es unknown
- 1998-06-25 TW TW087110254A patent/TW382597B/zh not_active IP Right Cessation
- 1998-06-25 AP APAP/P/1998/001279A patent/AP945A/en active
- 1998-06-26 PE PE1998000575A patent/PE97299A1/es not_active Application Discontinuation
- 1998-06-29 AR ARP980103145A patent/AR015916A1/es not_active Application Discontinuation
- 1998-06-29 UY UY25070A patent/UY25070A1/es not_active IP Right Cessation
- 1998-06-29 MY MYPI98002949A patent/MY119728A/en unknown
- 1998-06-29 GT GT199800090A patent/GT199800090A/es unknown
- 1998-06-30 DZ DZ980154A patent/DZ2544A1/xx active
- 1998-06-30 MA MA25145A patent/MA24586A1/fr unknown
- 1998-06-30 TN TNTNSN98123A patent/TNSN98123A1/fr unknown
- 1998-06-30 ZA ZA9805709A patent/ZA985709B/xx unknown
- 1998-07-01 CO CO98037136A patent/CO4940405A1/es unknown
- 1998-07-01 HR HR980378A patent/HRP980378B1/xx not_active IP Right Cessation
-
1999
- 1999-11-23 BG BG103917A patent/BG103917A/bg unknown
- 1999-11-23 IS IS5266A patent/IS5266A/is unknown
- 1999-12-23 OA OA9900306A patent/OA11246A/en unknown
- 1999-12-27 NO NO996492A patent/NO996492L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3276368B2 (ja) | 親油性薬剤用の2相放出配合物 | |
US7115565B2 (en) | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability | |
EP0713390B1 (en) | Gelatin capsules containing a highly concentrated acetaminophen solution | |
WO2003055466A1 (en) | Microemulsion preconcentrate | |
JP2004520398A (ja) | 経口生物学的利用能が改善されたパクリタキセルの化学療法マイクロエマルジョン組成物 | |
JPH11502842A (ja) | 結腸投与のためのアザチオプリン組成物 | |
JP2000512316A (ja) | セルトラリンのゼラチンカプセル封入溶液剤形 | |
US20220096461A1 (en) | Liquid oral dosage formulations of methylnaltrexone | |
US20030133974A1 (en) | Encapsulated solution dosage forms of sertraline | |
MXPA99012099A (en) | Gelatine encapsulated solution dosage forms of sertraline | |
CZ464299A3 (cs) | Želatinové zapouzdření roztokové dávkovači formy sertralinu | |
WO2005032516A1 (en) | Formulation and manufacturing process of self-microemulsified aceclofenac soft capsules | |
AU2002249926A1 (en) | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20031210 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040311 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040319 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040608 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040705 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040803 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |